Andrew J. Einhorn - 18 May 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc

Role
Chief Financial Officer
Signature
By: /s/ Christopher Klein, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 May 2021
Net transactions value
-$20,177
Form type
4
Filing time
20 May 2021, 16:06:04 UTC
Next filing
08 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Tax liability $20,177 -6,467 -4.1% $3.12* 151,080 18 May 2021 Direct
holding RVLP Ordinary Shares 22,852 18 May 2021 By family limited liability company F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.